Life insurers claim they stand to lose unless allowed access to applicants' genetic information, but consumers insist such data should remain out of bounds. Could both sides be right?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Alzheimer's Association. News release, 30 June 1995.
Post, S. G.et al. J. Am. Med. Assoc. 277, 832–836 (1997).
Pokorski, R. Nature 376, 13–14 (1995).
Pokorski, R. Am. J. Hum. Genet. 60, 205–216 (1997).
Murtaugh, C. M., Kemoer, P. & Spillman, B. C. Inquiry 32, 271–284 (1995).
Moses, S. A. Natl Underwriter 5 August 1996.
Weiner, J. J. Am. Med. Assoc. 271, 1525–1529 (1994).
Norton, E. C. & Newhouse, J. P. J. Am. Med. Assoc. 271, 1520–1524 (1994).
National Center for Human Genome Research, NIH publ. no. 93-3686 (1993).
Harper, P. S. Lancet 341, 224–227 (1993).
Moseley, R. et al. Report of the Human Genome Insurance Project, April 1995.
Author information
Authors and Affiliations
Author notes
The opinions in this paper are those of the author and not necessarily those of the organizations with which he is associated.
Rights and permissions
About this article
Cite this article
Pokorski, R. A test for the insurance industry. Nature 391, 835–836 (1998). https://doi.org/10.1038/35971
Issue Date:
DOI: https://doi.org/10.1038/35971
This article is cited by
-
Establishment of a method of anonymization of DNA samples in genetic research
Journal of Human Genetics (2003)
